Brief Overview of hyperlipidemia in primary care
A patient's lipid panel comes back, the LDL is elevated, and you have about ten minutes to decide whether this needs a statin, a recheck, or just lifestyle counseling. Here's how to make that call quickly and document it cleanly.
Dyslipidemia vs. hyperlipidemia: the terms
- Dyslipidemia is the broad term for abnormal cholesterol or lipid levels that raise cardiovascular risk. Medication may or may not be part of the plan.
- Hyperlipidemia is more specific. It means elevated total cholesterol, LDL, or triglycerides.
When to start screening
Recommendations vary by guideline. In general:
- Higher-risk patients (family history, metabolic syndrome, diabetes, smoking): start screening around age 20 to 30.
- Lower-risk patients: start around age 35 to 40.
- Men carry higher baseline risk, so earlier screening can be reasonable.
When to start a statin
Start statin therapy if any of these are present:
- History of stroke or coronary heart disease
- LDL greater than or equal to 190 mg/dL
- Diabetes, age 40 or older, with LDL 70 to 189 mg/dL
- LDL 70 to 189 mg/dL with a 10-year ASCVD risk of 7.5% or higher
ASCVD risk is the 10-year risk of stroke or heart attack. Most EMRs calculate it for you. The free ASCVD Plus app works too. You enter age, sex, race, blood pressure, lipid levels, and history.
Which statin to pick
- First-line: atorvastatin 10 to 20 mg daily. Recheck labs in about 2 months and adjust.
- If statin side effects like muscle cramps: switch to rosuvastatin 5 to 10 mg daily.
- If statins aren't tolerated: consider ezetimibe 10 mg daily.
Intensity should match risk. High-intensity statins (atorvastatin 40 to 80 mg, rosuvastatin 20 to 40 mg) lower LDL more than 50%. Moderate intensity lowers it 30 to 49%. For more on side effects and alternatives, see statin intolerance.
Clinical pearls for busy NPs
- Coding matters. Medicare often won't cover a lipid panel billed purely as screening. Use hyperlipidemia or Z13.220 (screening for lipid disorders). An annual physical code can sometimes work too.
- Baseline labs. Check baseline liver function (AST/ALT) before starting a statin.
- Follow-up. Repeat the lipid panel 4 to 12 weeks after starting or changing a dose, then every 3 to 12 months.
- True statin allergy is rare. Many patients tolerate a different statin or a lower dose.
- Lifestyle still counts. Statins work best alongside diet, exercise, weight management, and smoking cessation.
- Don't undertreat. Patients with ASCVD or LDL greater than or equal to 190 almost always need a statin. Lifestyle alone won't get there.
- Diabetes. Nearly all adults 40 and older with diabetes should be on a statin unless contraindicated.
Frequently asked questions
Do I need a fasting lipid panel?
For most patients a non-fasting panel is fine for screening and risk decisions. Fasting helps when triglycerides are very high or you're tracking them specifically.
What if the patient refuses a statin?
Document the conversation, the indication, and the shared decision. Offer lifestyle changes, recheck the panel, and revisit the statin at follow-up. Some patients come around once they see the numbers move or not move.
How soon do I recheck after starting?
Recheck the lipid panel in about 4 to 12 weeks to see the response and confirm adherence, then space it out to every 3 to 12 months.
Cholesterol management is one of the highest-yield things you do in primary care, and most of it comes down to a few clear decision points. For a one-page version you can keep open during a visit, the Clinical Desk Reference covers it. If you want the full workup, the Primary Care Clinical Mastery Program walks through lipid management start to finish. You can also read more on the coronary artery calcium test when risk is borderline.
Education only. Use clinical judgment and your local guidelines.
Written by Allison Sowders, MSN, APRN, FNP-BC, a practicing primary care nurse practitioner and founder of Nurse Practitioner Mentor. Reviewed July 2026.
Stay connected with news and updates!
Join the mailing list to receive the latest news and updates. Don't worry, your information will not be shared.
We hate SPAM. We will never sell your information, for any reason.